CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches.
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
2025年4月7日,第2届国际CIK细胞会议在意大利蒙扎举行,标志着国际CIK细胞学会(ISCC)的成立。本次会议得到了意大利Fondazione Tettamanti的慷慨支持,展示了细胞因子诱导的杀伤(CIK)细胞免疫治疗单独使用以及与树突状细胞(DC-CIK)和嵌合抗原受体(CAR-CIK)联合应用的前沿进展。此次活动还为年轻研究者提供了宝贵机会,使他们能够参与富有洞见的讨论,并与该领域专家建立联系。
On April 7, 2025, the 2nd International CIK Cell Conference was held in Monza, Italy, marking the establishment of the International Society for CIK Cells (ISCC).
The conference, kindly supported by Fondazione Tettamanti (Italy), featured cutting-edge advancements in cytokine-induced killer (CIK) cell immunotherapy, used alone and in combination with dendritic cells (DC-CIK) and chimeric antigen receptors (CAR-CIK). The event also provided a valuable opportunity for young investigators to engage in insightful discussions and to network within experts in the field.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。